Cadent Capital Advisors LLC Purchases New Position in UnitedHealth Group Incorporated (NYSE:UNH)

Cadent Capital Advisors LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 922 shares of the healthcare conglomerate’s stock, valued at approximately $539,000.

Several other large investors have also recently modified their holdings of the stock. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group in the third quarter valued at $27,000. Macroview Investment Management LLC boosted its stake in shares of UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the period. Delos Wealth Advisors LLC lifted its holdings in UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 2nd quarter worth $31,000. Finally, Global Wealth Strategies & Associates lifted its position in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.6 %

UNH stock opened at $569.61 on Friday. The firm’s fifty day moving average is $584.42 and its 200 day moving average is $534.15. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $608.63. The firm has a market cap of $524.26 billion, a PE ratio of 34.82, a P/E/G ratio of 1.69 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. UnitedHealth Group’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.56 EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 27.68 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.47%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

Analyst Ratings Changes

UNH has been the subject of several analyst reports. Morgan Stanley decreased their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday. HSBC downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday. Stephens decreased their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday. Royal Bank of Canada cut their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday. Finally, Hsbc Global Res lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $615.58.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.